Insurance companies could be required to disclose the amount that patients are responsible for paying for their prescription drugs as part of a proposal from the Trump administration.
Patients could take action on the information if they have it while in treatment and share it with their doctors, Rachel Sachs, a law professor at the Washington University in St. Louis who studies drug pricing, said.
That would be a change from now. However, patients may still not have those real-time conversations with doctors about what they’re paying for drugs, Mike Strazzella, leader of the federal government relations department at Buchanan, ...